• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Ifosfamide IC50

To identify genes influencing blood pressure response to an angiotensin II

September 9, 2017 by Katherine Lewis Leave a Comment

To identify genes influencing blood pressure response to an angiotensin II receptor blocker, single nucleotide polymorphisms recognized by genome-wide association analysis of the response to candesartan were validated by reverse direction associations with the response to a thiazide diuretic, hydrochlorothiazide. AA genotype, the mean systolic BP/diastolic BP reactions to hydrochlorothiazide were 4.7/6.3 mmHg less for … [Read more…]

Posted in: Blogging Tagged: Ifosfamide IC50, Mouse monoclonal to BNP

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by